Celldex Therapeutics, Inc.·4

Jun 15, 7:42 AM ET

KELER TIBOR 4

4 · Celldex Therapeutics, Inc. · Filed Jun 15, 2018

Insider Transaction Report

Form 4
Period: 2018-06-13
KELER TIBOR
Sr. VP & CSO
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2018-06-13+390,000390,000 total
    Exercise: $0.60From: 2019-06-13Exp: 2028-06-13Common Stock (390,000 underlying)
Footnotes (2)
  • [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
  • [F2]25% vest on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Documents

2 files